Showing results (1361-1370 of 1,588) with videos related to
Sort By:
Pageof 159
JNCI Cancer Spectrum|March 8, 2026
Chronic exercise training intensity, immune cells, and cancer outcomes: a scoping reviewDong-Woo Kang, Kerry S Courneya, Maria C Swartz, et al.Wellcome Open Research|October 12, 2017
A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, MalawiStephen B Gordon, Jamie Rylance, Amy Luck, et al.Perioperative Medicine (London, England)|April 13, 2018
Correction to: American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) Joint Consensus Statement on Optimal Analgesia within an Enhanced Recovery Pathway for Colorectal Surgery: Part 2-From PACU to the Transition HomeMichael J Scott, Matthew D McEvoy, Debra B Gordon, et al.Journal of Medical Genetics|December 7, 2016
A novel somatic mutation achieves partial rescue in a child with Hutchinson-Gilford progeria syndromeDaniel Z Bar, Martin F Arlt, Joan F Brazier, et al.Environmental Science & Technology|March 5, 2004
Multilevel cycle of anthropogenic copperT E Graedel, D van Beers, M Bertram, et al.The Journal of Endocrinology|August 1, 1979
Changes in the concentration of 5-methoxytryptophol in the circulation at different phases of the human menstrual cycleR J Hooper, R E Silman, R M Leone, et al.Dermatology and Therapy|January 20, 2022
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge StudyJeffrey J Crowley, Richard G Langley, Kenneth B Gordon, et al.European Heart Journal|May 10, 2014
Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathyChristiane Gruner, Raymond H Chan, Andrew Crean, et al.The Journal of Dermatological Treatment|May 1, 2020
Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trialsK B Gordon, K Reich, J J Crowley, et al.Journal of Virology|September 29, 2022
Unique Evolution of Antiviral Tetherin in BatsJoshua A Hayward, Mary Tachedjian, Adam Johnson, et al.Pageof 159